Cargando…

High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients

Transforming growth factor beta (TGF-β) promotes the pathogenesis of hepatocellular carcinoma (HCC). We evaluated the associations between TGF-β1 expression and clinicopathological parameters in HCC patients from The Cancer Genome Atlas (TCGA), as well as the prognostic power of TGF-β1 expression. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Li, Yuan, Xiao-Qing, Zhang, Chao-Yang, Ye, Fei, Zhou, Hui-Fang, Li, Wen-Ling, Liu, Zhao-Yang, Zhang, Ya-Qin, Pan, Xi, Li, Guan-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470976/ https://www.ncbi.nlm.nih.gov/pubmed/28415739 http://dx.doi.org/10.18632/oncotarget.16166

Ejemplares similares

Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma
por: Ruan, Haoyu, et al.
Publicado: (2016)

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
por: Turato, C, et al.
Publicado: (2014)

The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma
por: Ji, Fei, et al.
Publicado: (2015)

The emergence of long non-coding RNAs in hepatocellular carcinoma: an update
por: Peng, Li, et al.
Publicado: (2018)

High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity
por: Jin, Xiuli, et al.
Publicado: (2022)

MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma
por: Chen, Wei-xun, et al.
Publicado: (2016)

AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway
por: Wang, Miao, et al.
Publicado: (2018)

High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma
por: Wang, Wen-yao, et al.
Publicado: (2014)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
por: Chou, Jian-Liang, et al.
Publicado: (2015)

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
por: Zhao, Gang, et al.
Publicado: (2013)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation
por: Ma, Kun, et al.
Publicado: (2020)

Key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma
por: Ye, Guan-Chao, et al.
Publicado: (2021)

Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer
por: dos Reis, Sabrina Thalita, et al.
Publicado: (2011)

Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer
por: Li, Hengcun, et al.
Publicado: (2019)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis
por: Wang, Qing, et al.
Publicado: (2011)

High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway
por: Zhou, Ke, et al.
Publicado: (2019)

DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Jin, et al.
Publicado: (2019)

Down‐regulation of TROP‐2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients
por: Sin, Sarah T. K., et al.
Publicado: (2018)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Bu, Yang, et al.
Publicado: (2016)

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling
por: Liu, Fang, et al.
Publicado: (2015)

Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma
por: Liu, Xu, et al.
Publicado: (2015)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014)

FGFR4 and TGF-β1 Expression in Hepatocellular Carcinoma: Correlation with Clinicopathological Features and Prognosis
por: Chen, Zhixin, et al.
Publicado: (2013)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
por: He, Lin, et al.
Publicado: (2019)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma
por: Yu, Dan-Dan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ut8sh3541bpk0i7cp0fqmkitv1